title: Resistance to discodermolide, a microtubule-stabilizing agent and senescence inducer, is 4E-BP1-dependent.
abstract: Discodermolide is a microtubule-stabilizing agent that induces accelerated cell senescence. A discodermolide-resistant cell line, AD32, was generated from the human lung cancer cell line A549. We hypothesize that the major resistance mechanism in these cells is escape from accelerated senescence. AD32 cells have decreased levels of 4E-BP1 mRNA and protein, relative to the parental discodermolide-sensitive A549 cells. Lentiviral-mediated re-expression of wild-type 4E-BP1 in AD32 cells increased the proliferation rate and reverted resistance to discodermolide via restoration of discodermolide-induced accelerated senescence. Consistent with this, cell growth and response to discodermolide was confirmed in vivo using tumor xenograft models. Furthermore, reintroduction of a nonphosphorylatable mutant (Thr-37/46 Ala) of 4E-BP1 was able to partially restore sensitivity and enhance proliferation in AD32 cells, suggesting that these effects are independent of phosphorylation by mTORC1. Microarray profiling of AD32-resistant cells versus sensitive A549 cells, and subsequent unbiased gene ontology analysis, identified molecular pathways and functional groupings of differentially expressed mRNAs implicated in overcoming discodermolide-induced senescence. The most statistically significant classes of differentially expressed genes included p53 signaling, G2/M checkpoint regulation, and genes involved in the role of BRCA1 in the DNA damage response. Consistent with this, p53 protein expression was up-regulated and had increased nuclear localization in AD32 cells relative to parental A549 cells. Furthermore, the stability of p53 was enhanced in AD32 cells. Our studies propose a role for 4E-BP1 as a regulator of discodermolide-induced accelerated senescence.
authors.affiliation: Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
authors.forename: Suzan K
authors.initials: SK
authors.lastname: Chao
authors.forename: Juan
authors.initials: J
authors.lastname: Lin
authors.forename: Jurriaan
authors.initials: J
authors.lastname: Brouwer-Visser
authors.forename: Amos B
authors.initials: AB
authors.lastname: Smith
authors.forename: Susan Band
authors.initials: SB
authors.lastname: Horwitz
authors.forename: Hayley M
authors.initials: HM
authors.lastname: McDaid
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics / Q000378:metabolism*; D000473:Alkanes / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002219:Carbamates / Q000494:pharmacology*; D018797:Cell Cycle Proteins; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D016922:Cellular Senescence / Q000187:drug effects*; D019008:Drug Resistance, Neoplasm / Q000502:physiology*; D005260:Female; D005455:Fluorescent Antibody Technique; D005786:Gene Expression Regulation / Q000187:drug effects*; D005822:Genetic Vectors; D006801:Humans; D015151:Immunoblotting; D007150:Immunohistochemistry; D007783:Lactones / Q000494:pharmacology*; D016086:Lentivirus; D051379:Mice; D046228:Microarray Analysis; D017239:Paclitaxel / Q000494:pharmacology; D010750:Phosphoproteins / Q000235:genetics / Q000378:metabolism*; D011753:Pyrones / Q000494:pharmacology*; D014161:Transduction, Genetic; D050257:Tubulin Modulators / Q000494:pharmacology*; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism; D001616:beta-Galactosidase / Q000378:metabolism
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D000473:Alkanes; D000970:Antineoplastic Agents; D002219:Carbamates; D018797:Cell Cycle Proteins; C087000:EIF4EBP1 protein, human; D007783:Lactones; D010750:Phosphoproteins; D011753:Pyrones; D050257:Tubulin Modulators; D016159:Tumor Suppressor Protein p53; C071229:discodermolide; D001616:beta-Galactosidase; D017239:Paclitaxel